BGB-8035

• Target:

  BTK|||EGFR

• Related Pathways:

  JAK/STAT signaling|||Angiogenesis|||Tyrosine Kinase/Adaptors

• Purity:

  0.9674

• Bioactivity:

  BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.

• Smiles:

  C (N) (=O) C1=C2N ([C@@H] (CCN2) C3CCN (C (C=C) =O) CC3) N=C1C4=CC (OC) =C (C) C (OC) =C4

• Molecular Formula:

  C24H31N5O4

• Molecular Weight:

  453.53

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2283349-24-4